Triperiden is an inhibitor of influenza virus replication; it exhibits antiviral activity by targeting the haemagglutinin of fowl plague virus (FPV) and inhibiting its conformational change at acidic pH; it also acts as an anticholinergic agent with anti-Parkinsonian activity.